A key paper on financing biomedical innovation: link here.
Review of literature on financial intermediation in the process by which new medical therapeutics are financed, developed, and delivered. […]
DULBEA, Solidaris & CIRIEC – 16th of November – Dupréel Room (ULB Solbosch)
In collaboration with Solidaris and CIRIEC, the DULBEA is organising an international conference on the 16th of November 2022 […]
Registrations for the 8th edition of the Interdisciplinary Program is now open.
Full program will be available soon.
Please find all the information on our dedicated page: here […]
Le Pr Michel Goldman (Professeur émérite d’immunologie et président de l’Institut interdisciplinaire pour l’innovation en santé à l’ULB) vient de publier un article consacré au Covid long dans Frontiers […]
Quel intérêt pour le dosage des anticorps anti-Covid ? Ci-dessous les réponses de Michel Goldman à Laurence Dardenne dans La Libre.
Register now to the Round table of the HealthTech Innovation Days: “Build tomorrow’s healthcare for all European citizen”
The conference will take place on […]
Scientific progress in the treatment of rare diseases is both an opportunity to improve lives and a financial challenge given the high cost of therapies. As stressed by […]
A lifelong promoter of vaccines suspects he might be the rare, unfortunate exception. On September 22 of last year, Michel Goldman, a Belgian immunologist and one of Europe’s […]
L’immunologiste Michel Goldman (ULB) cosigne un ouvrage sur les vaccins à destination d’un public non averti. Pédagogique mais jamais pédant, il vient en parler dans des classes de 6e […]
In 2022, the National Academy of Technologies of France will host this event for which the theme is « Engineering a better world – Breakthrough Technologies for Healthcare […]
